NFKB1 and diffuse large B-cell lymphoma: Expression of CD30 (48%), NF-κB p50 (69%) and pSTAT3 (38%) were more commonly observed in EBV+ DLBCL (p = 0.0003, p = 0.0056 and p = 0.0389, respectively).